FDA Inspection
Versiti Blood Health, IncVersiti Blood Health, Inc – FDA Inspection, Apr 19, 2013
Record Details
This FDA Inspection record concerns Versiti Blood Health, Inc, with an inspection on April 19, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Versiti Blood Health, Inc
- Inspection Date
- April 19, 2013
- Product Type
- Biologics
View Company Profile
ID · 1524eae9-079b-4067-8f3c-93cd895a829b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 833367
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Versiti Blood Health, Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2026 | Not classified | Detroit District Office | Human Cellular, Tissue, and Gene Therapies |
| September 30, 2024 | VAI | Detroit District Office | Blood and Blood Products |
| May 7, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 17, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Versiti Blood Health, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.